Dicerna Pharmaceuticals reported $0 in Loan Capital for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Loan Capital Change
Agenus AGEN:US $ 18.91M 0.03M
Alnylam Pharmaceuticals ALNY:US $ 191.59M 0.31M
Amgen AMGN:US $ 31129M 1766M
Arrowhead Research ARWR:US $ 0 0
Biogen BIIB:US $ 7267.2M 159M
Bluebird Bio BLUE:US $ 0M 0M
Dicerna Pharmaceuticals DRNA:US $ 0M 0M
GlaxoSmithKline GSK:LN 23047M 378M
Immunogen IMGN:US $ 0M 0M
Intercept Pharmaceuticals ICPT:US $ 568.11M 7.53M
Intrexon XON:US $ 174.16M 2.64M
IONIS PHARMACEUT IONS:US $ 870.92M 347.1M
Karyopharm Therapeutics KPTI:US $ 241.79M 50.78M
Lexicon Pharmaceuticals LXRX:US $ 0M 0M
Macrogenics MGNX:US $ 0 0
Mirati Therapeutics MRTX:US $ 0M 0M
Regeneron Pharmaceuticals REGN:US $ 1978.9M 716.8M
Ultragenyx Pharmaceutical RARE:US $ 0M 0.7M